Taiwan Creates National Vaccine Fund To Stabilize National Supplies
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - Taiwan plans to create a national vaccine fund as early as next year to stabilize the country's supply and streamline decisions on new purchases
You may also be interested in...
Taiwan To Establish Vaccine Foundation, Will Boost Vaccine Sales
SHANGHAI - Taiwan's Department of Health will establish a vaccine foundation this year for combating communicable diseases, the department announced at a Jan. 5 conference
Taiwan To Establish Vaccine Foundation, Will Boost Vaccine Sales
SHANGHAI - Taiwan's Department of Health will establish a vaccine foundation this year for combating communicable diseases, the department announced at a Jan. 5 conference
Polaris Taiwan Subsidiary TDW To Begin Phase III Trials Of Liver Cancer Drug
HONG KONG - Phase III clinical trials are slated to start next year on anti-cancer drug ADI-PEG 20 by U.S.-based Polaris Group's Taiwan subsidiary TDW Pharmaceuticals following successful Phase II trials that included recovery by a cancer patient deemed to have six months to live several years ago